NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,263,477 | -9.0% | 287,291 | -9.9% | 0.05% | -4.0% |
| Q2 2023 | $32,163,117 | +2.2% | 318,731 | -6.8% | 0.05% | -5.7% |
| Q1 2023 | $31,473,095 | +5.5% | 342,099 | +4.1% | 0.05% | -3.6% |
| Q4 2022 | $29,821,310 | +12.8% | 328,718 | -5.5% | 0.06% | +7.8% |
| Q3 2022 | $26,448,000 | -11.1% | 347,948 | -1.1% | 0.05% | -8.9% |
| Q2 2022 | $29,751,000 | -1.6% | 351,959 | +2.1% | 0.06% | +24.4% |
| Q1 2022 | $30,235,000 | +2.6% | 344,557 | +2.2% | 0.04% | +21.6% |
| Q4 2021 | $29,483,000 | +2.3% | 337,059 | -4.4% | 0.04% | -14.0% |
| Q3 2021 | $28,824,000 | +1.4% | 352,454 | +13.1% | 0.04% | 0.0% |
| Q2 2021 | $28,437,000 | +11.9% | 311,673 | +4.9% | 0.04% | 0.0% |
| Q1 2021 | $25,402,000 | -9.7% | 297,153 | -0.3% | 0.04% | -14.0% |
| Q4 2020 | $28,134,000 | +6.6% | 297,949 | -1.9% | 0.05% | -9.1% |
| Q3 2020 | $26,404,000 | -4.2% | 303,633 | -3.8% | 0.06% | -14.1% |
| Q2 2020 | $27,573,000 | +5.9% | 315,690 | -0.0% | 0.06% | -20.0% |
| Q1 2020 | $26,037,000 | -15.0% | 315,782 | -2.3% | 0.08% | +2.6% |
| Q4 2019 | $30,616,000 | +2.4% | 323,325 | -6.0% | 0.08% | -7.1% |
| Q3 2019 | $29,887,000 | -5.4% | 343,926 | -0.6% | 0.08% | -6.7% |
| Q2 2019 | $31,581,000 | -6.6% | 345,864 | -1.7% | 0.09% | -6.2% |
| Q1 2019 | $33,820,000 | +10.9% | 351,780 | -1.0% | 0.10% | -5.9% |
| Q4 2018 | $30,502,000 | +1.3% | 355,464 | +1.8% | 0.10% | +18.6% |
| Q3 2018 | $30,099,000 | +11.7% | 349,330 | -2.1% | 0.09% | +3.6% |
| Q2 2018 | $26,944,000 | -10.6% | 356,688 | -4.3% | 0.08% | -14.4% |
| Q1 2018 | $30,142,000 | -2.2% | 372,806 | +1.5% | 0.10% | -1.0% |
| Q4 2017 | $30,835,000 | +1.4% | 367,252 | +3.7% | 0.10% | -3.0% |
| Q3 2017 | $30,403,000 | +0.4% | 354,147 | -2.3% | 0.10% | +8.6% |
| Q2 2017 | $30,267,000 | +9.7% | 362,616 | -2.4% | 0.09% | -1.1% |
| Q1 2017 | $27,598,000 | -6.8% | 371,586 | -8.6% | 0.09% | -11.3% |
| Q4 2016 | $29,609,000 | -21.3% | 406,497 | -14.7% | 0.11% | -17.8% |
| Q3 2016 | $37,612,000 | -7.1% | 476,363 | -3.0% | 0.13% | -9.2% |
| Q2 2016 | $40,504,000 | +4.9% | 490,907 | -7.9% | 0.14% | +6.8% |
| Q1 2016 | $38,617,000 | -28.1% | 533,100 | -14.7% | 0.13% | -26.9% |
| Q4 2015 | $53,744,000 | -15.8% | 624,629 | -10.1% | 0.18% | -20.2% |
| Q3 2015 | $63,852,000 | -12.1% | 694,652 | -6.0% | 0.23% | -3.8% |
| Q2 2015 | $72,641,000 | -7.9% | 738,696 | -7.6% | 0.24% | -5.6% |
| Q1 2015 | $78,850,000 | -3.0% | 799,614 | -8.9% | 0.25% | -2.0% |
| Q4 2014 | $81,320,000 | -2.9% | 877,626 | -1.3% | 0.26% | -4.8% |
| Q3 2014 | $83,720,000 | +3.3% | 889,407 | -0.6% | 0.27% | +5.5% |
| Q2 2014 | $81,041,000 | +3.8% | 895,183 | -2.5% | 0.26% | +2.4% |
| Q1 2014 | $78,066,000 | +1.7% | 918,199 | -3.8% | 0.25% | 0.0% |
| Q4 2013 | $76,733,000 | +8.5% | 954,640 | +3.5% | 0.25% | -1.6% |
| Q3 2013 | $70,732,000 | +11.0% | 922,063 | +2.3% | 0.25% | -0.8% |
| Q2 2013 | $63,745,000 | – | 901,507 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |